Expression data from human patients with slow or rapid Parkinson's Disease progression
Ontology highlight
ABSTRACT: Parkinson’s Disease is a multi-system, disabling progressive neurodegenerative condition. Clinical progression is highly heterogeneous and, thus far, there are not available biomarkers to accurately predict the rate of disease progression. Thus, identifying molecular signatures that allow discriminating between different progression rates might significantly assist the therapeutic strategy, and enable improved outcomes in clinical trials. We performed an exploratory cross-sectional study aimed at determining whether gene expression differences in peripheral blood may be used to discriminate between patients with slow or rapid Parkinson’s disease progression
ORGANISM(S): Homo sapiens
PROVIDER: GSE80599 | GEO | 2016/04/25
SECONDARY ACCESSION(S): PRJNA319440
REPOSITORIES: GEO
ACCESS DATA